141 related articles for article (PubMed ID: 9372243)
1. Regulation of fibroblast growth factor 2 expression in melanoma cells by the c-MYB proto-oncoprotein.
Miglarese MR; Halaban R; Gibson NW
Cell Growth Differ; 1997 Nov; 8(11):1199-210. PubMed ID: 9372243
[TBL] [Abstract][Full Text] [Related]
2. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
Lennartsson A; Garwicz D; Lindmark A; Gullberg U
Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
[TBL] [Abstract][Full Text] [Related]
3. The functional -443T/C osteopontin promoter polymorphism influences osteopontin gene expression in melanoma cells via binding of c-Myb transcription factor.
Schultz J; Lorenz P; Ibrahim SM; Kundt G; Gross G; Kunz M
Mol Carcinog; 2009 Jan; 48(1):14-23. PubMed ID: 18459127
[TBL] [Abstract][Full Text] [Related]
4. TATA-box dependent trans-activation of the human HSP70 promoter by Myb proteins.
Foos G; Natour S; Klempnauer KH
Oncogene; 1993 Jul; 8(7):1775-82. PubMed ID: 8510924
[TBL] [Abstract][Full Text] [Related]
5. B-MYB transactivates its own promoter through SP1-binding sites.
Sala A; Saitta B; De Luca P; Cervellera MN; Casella I; Lewis RE; Watson R; Peschle C
Oncogene; 1999 Feb; 18(6):1333-9. PubMed ID: 10022815
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the promoter for the human antisense fibroblast growth factor-2 gene; regulation by Ets in Jurkat T cells.
Gagnon ML; Moy GK; Klagsbrun M
J Cell Biochem; 1999 Mar; 72(4):492-506. PubMed ID: 10022609
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation by the carboxyl terminus of c-Myb depends upon both the Myb DNA-binding domain and the DNA recognition site.
Dubendorff JW; Lipsick JS
Oncogene; 1999 Jun; 18(23):3452-60. PubMed ID: 10376523
[TBL] [Abstract][Full Text] [Related]
8. DNA binding-independent transcriptional activation of the vascular endothelial growth factor gene (VEGF) by the Myb oncoprotein.
Lutwyche JK; Keough RA; Hunter J; Coles LS; Gonda TJ
Biochem Biophys Res Commun; 2006 Jun; 344(4):1300-7. PubMed ID: 16650815
[TBL] [Abstract][Full Text] [Related]
9. Studies of c-myb gene regulation in MRL-lpr/lpr mice. Identification of a 5' c-myb nuclear protein binding site and high levels of binding factors in nuclear extracts of lpr/lpr lymph node cells.
Mountz JD; Steinberg AD
J Immunol; 1989 Jan; 142(1):328-35. PubMed ID: 2642505
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of the human A-myb promoter: regulation by NF-Y and Sp1.
Facchinetti V; Lopa R; Spreafico F; Bolognese F; Mantovani R; Tavner F; Watson R; Introna M; Golay J
Oncogene; 2000 Aug; 19(34):3931-40. PubMed ID: 10951586
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of a c-Myb/estrogen receptor fusion protein in transformed primary cells leads to granulocyte/macrophage differentiation and down regulation of c-kit but not c-myc or cdc2.
Hogg A; Schirm S; Nakagoshi H; Bartley P; Ishii S; Bishop JM; Gonda TJ
Oncogene; 1997 Dec; 15(24):2885-98. PubMed ID: 9416832
[TBL] [Abstract][Full Text] [Related]
12. Regulation of expression of MSG1 melanocyte-specific nuclear protein in human melanocytes and melanoma cells.
Li H; Ahmed NU; Fenner MH; Ueda M; Isselbacher KJ; Shioda T
Exp Cell Res; 1998 Aug; 242(2):478-86. PubMed ID: 9683535
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional activation potential of normal and tumor-associated myb isoforms does not correlate with their ability to block GCSF-induced terminal differentiation of murine myeloid precursor cells.
Patel G; Tantravahi R; Oh IH; Reddy EP
Oncogene; 1996 Sep; 13(6):1197-208. PubMed ID: 8808694
[TBL] [Abstract][Full Text] [Related]
14. Human c-myb is expressed in cervical carcinomas and transactivates the HPV-16 promoter.
Nürnberg W; Artuc M; Nawrath M; Lovric J; Stüting S; Moelling K; Czarnetzki BM; Schadendorf D
Cancer Res; 1995 Oct; 55(19):4432-7. PubMed ID: 7671256
[TBL] [Abstract][Full Text] [Related]
15. The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells.
Wang P; Branch DR; Bali M; Schultz GA; Goss PE; Jin T
Biochem J; 2003 Oct; 375(Pt 1):199-205. PubMed ID: 12841847
[TBL] [Abstract][Full Text] [Related]
16. A Myb dependent pathway maintains Friend murine erythroleukemia cells in an immature and proliferating state.
Chen J; Kremer CS; Bender TP
Oncogene; 2002 Mar; 21(12):1859-69. PubMed ID: 11896618
[TBL] [Abstract][Full Text] [Related]
17. The interferon regulatory factors 1 and 2 bind to a segment of the human c-myb first intron: possible role in the regulation of c-myb expression.
Manzella L; Gualdi R; Perrotti D; Nicolaides NC; Girlando G; Giuffrida MA; Messina A; Calabretta B
Exp Cell Res; 2000 Apr; 256(1):248-56. PubMed ID: 10739671
[TBL] [Abstract][Full Text] [Related]
18. B-myb transcriptional regulation and mRNA stability during differentiation of neuroblastoma cells.
Raschellà G; Negroni A; Pucci S; Amendola R; Valeri S; Calabretta B
Exp Cell Res; 1996 Feb; 222(2):395-9. PubMed ID: 8598228
[TBL] [Abstract][Full Text] [Related]
19. Flexibility in the second half-site sequence recognised by the c-Myb R2 domain--in vitro and in vivo analysis.
Ording E; Bergholtz S; Brendeford EM; Jamin N; Gabrielsen OS
Oncogene; 1996 Sep; 13(5):1043-51. PubMed ID: 8806694
[TBL] [Abstract][Full Text] [Related]
20. SKI activates Wnt/beta-catenin signaling in human melanoma.
Chen D; Xu W; Bales E; Colmenares C; Conacci-Sorrell M; Ishii S; Stavnezer E; Campisi J; Fisher DE; Ben-Ze'ev A; Medrano EE
Cancer Res; 2003 Oct; 63(20):6626-34. PubMed ID: 14583455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
